Skip to content
FY'25FY'24FY'23FY'22
-$546.38M-75.0%-$312.22M-1.8%-$306.74M+2.4%-$314.25M-73.4%
$12.99M-5.7%$13.77M+20.2%$11.46M+20.9%$9.48M+31.7%
$41.67M-41.3%$71.04M-1.5%$72.12M-8.3%$78.61M+7.2%
-$111.21M+46.0%-$206.06M+20.5%-$259.17M+1.5%-$263.21M-137%
$2.8M$8.84M-47.2%$16.75M+182%
$115.45M-6.9%$124M$116.08M+116%
-$42.99M$9.62M-99.2%
$7.67M-$145.68M
-$113.92M+46.3%-$212.25M+20.8%-$268.02M+4.3%-$279.96M-139%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How much cash does Pacific Biosciences of California generate?
Pacific Biosciences of California (PACB) generated -$111.8M in operating cash flow over the trailing twelve months.
What is Pacific Biosciences of California's free cash flow?
After $4.5M of capital expenditures, Pacific Biosciences of California's free cash flow was -$116.2M over the trailing twelve months, up 34.8% year over year.
Where does Pacific Biosciences of California's cash flow data come from?
Every line is extracted from Pacific Biosciences of California's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.